Literature DB >> 8500317

Artificial tear composition and promotion of recovery of the damaged corneal epithelium.

D Lopez Bernal1, J L Ubels.   

Abstract

In severe dry eye syndromes the corneal epithelium is compromised with development of punctate erosions and increased permeability. In the present study the ability of artificial tear solutions to promote recovery of the corneal epithelial barrier was determined by measurement of corneal uptake of 5,6 carboxyfluorescein (CF). Corneas of anesthetized rabbits were exposed to 0.01% benzalkonium for 5 min to increase epithelial permeability. The cornea was then exposed to an artificial tear solution for 1.5 h followed by measurement of CF uptake. During exposure to three commercial isotonic, nonpreserved solutions and a solution preserved with polyquaternium-1, CF uptake decreased significantly but did not return to control. No recovery of the epithelial barrier occurred during exposure of corneas to nonpreserved hypotonic solutions. During exposure to an experimental tear solution with an electrolyte composition similar to human tears, buffered with bicarbonate, CF uptake returned to control levels. Bicarbonate is an essential component of this solution because the same formula buffered with borate or without buffer was ineffective in promoting recovery of the damaged corneal epithelium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500317     DOI: 10.1097/00003226-199303000-00004

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  10 in total

1.  [Epitheliotrophic capacity of serum and plasma eyedrops. Influence of centrifugation].

Authors:  P Herminghaus; G Geerling; D Hartwig; T Wedel; L Dibbelt
Journal:  Ophthalmologe       Date:  2004-10       Impact factor: 1.059

2.  Gene expression in human accessory lacrimal glands of Wolfring.

Authors:  John L Ubels; Ilene K Gipson; Sandra J Spurr-Michaud; Ann S Tisdale; Rachel E Van Dyken; Mark P Hatton
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-01       Impact factor: 4.799

3.  New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery.

Authors:  K Tsubota; Y Monden; Y Yagi; E Goto; S Shimmura
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

4.  Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis.

Authors:  Kyoung Min Kim; Yong-Tae Shin; Hong Kyun Kim
Journal:  Jpn J Ophthalmol       Date:  2012-09-13       Impact factor: 2.447

Review 5.  Autologous serum eye drops for ocular surface disorders.

Authors:  G Geerling; S Maclennan; D Hartwig
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

6.  Evaluation of artificial tears on cornea epithelium healing.

Authors:  Ying Zhang; Xiao-You Lu; Ren-Jian Hu; Fang-Li Fan; Xiu-Ming Jin
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

7.  The Ex Vivo Eye Irritation Test (EVEIT) in evaluation of artificial tears: Purite-preserved versus unpreserved eye drops.

Authors:  N Schrage; M Frentz; F Spoeler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-15       Impact factor: 3.117

8.  Effect of different artificial tears against desiccation in cultured human epithelial cells.

Authors:  Frank Tost; Ramona Keiss; Rico Großjohann; Clemens Jürgens; Jürgen Giebel
Journal:  Med Sci Monit       Date:  2012-05

Review 9.  Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.

Authors:  Terry G Coursey; Cintia S de Paiva
Journal:  Clin Ophthalmol       Date:  2014-08-04

Review 10.  Formulation Considerations for the Management of Dry Eye Disease.

Authors:  Priyanka Agarwal; Jennifer P Craig; Ilva D Rupenthal
Journal:  Pharmaceutics       Date:  2021-02-03       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.